Teladoc, Inc. has teamed up with Accolade, an on-demand healthcare concierge provider, to help members navigate their telehealth benefits. The integrated service is now available to several of the two companies’ shared clients and is showing an increased utilization of Teladoc’s offerings. Teladoc’s shares gained 2.79% to $23.95 on March 21.
The company’s shares outstanding are recorded as 54.24 million and total shares floated are 53.00 million. Current ratio—the relationship between current assets and current liabilities—is calculated as 3.90. Teladoc’s distance from the 20-day simple moving average is 11.24%, and distance from the 50-day simple moving average is 17.78%. The stock has gotten OUTPERFORM ratings from seven analysts from Thomson Reuters, no analyst gave a HOLD rating and none gave an UNDERPERFORM rating. The analysts’ mean target price for TDOC is $26.00, while their mean recommendation is 1.70.
Teladoc’s yearly performance is 113.27% and net profit margin is -60.30%. The current share price indicates that the stock is 0.84% away from its one-year high and is moving 163.77% ahead of its 52-week low.
Accolade, a McKesson Ventures portfolio company, provides health care concierge service for employers, health plans, health systems, and employees. It has been recognized as one of the nation’s 25 most promising companies by Forbes magazine and the fastest-growing private healthcare company by Inc. 500.
Read the full story here.